- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 4.19M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 3.23M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 451.99K sh |
| Capex | Q1 2026 · Mar 31, 2026 | $0 |
| Capex | Q1 2026 · Mar 31, 2025 | $6K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$3.65M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.45M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $2.41M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $5.99M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $291K |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.6M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $4.06M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $2.76M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $4.31M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.61M |
| Total Liabilities | Q1 2026 · Mar 31, 2025 | $5.72M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $4.07M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $6.64M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.6M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $7.22M |
| Total Assets | Q1 2026 · Mar 31, 2025 | $8.31M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.85 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $3.84 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.85 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | $3.84 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.38M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.06M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $1.37M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $590K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.73M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.74M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$2.75M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.65M |